Tezepelumab Improves Small Airways Dysfunction in Severe Asthma: A 52‐Week Real‐World Study

Clinical and Translational Allergy · Published 2026-01-01 · DOI 10.1002/clt2.70147

Authors being retrieved — see the publisher record. https://doi.org/10.1002/clt2.70147

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year: 2026

Related articles

Improved peripheral airway reactance is associated with clinical remission following biologic therapy in severe asthma · Annals of Allergy, Asthma and Immunology · 2026 · Cites or is cited by this article
Sexual Health in Atopic Dermatitis: Impact of Skin Clinical Control · Clinical and Translational Allergy · 2025 · Same journal
Temporal Patterns of Allergen Sensitisation in the General Population: The LEAD Study · Clinical and Translational Allergy · 2026 · Same journal
Staphylococcus aureus and Staphylococcus lugdunensis Act in Concert to Disrupt the Nasal Epithelial Barrier · Clinical and Translational Allergy · 2026 · Same journal
IL‐25 Disrupts the Nasal Epithelial Barrier in an Adapter Act1‐Dependent Manner · Clinical and Translational Allergy · 2026 · Same journal
Integrated Immune, Epithelial and Lipid Pathways in NSAID‐Exacerbated Respiratory Disease · Clinical and Translational Allergy · 2026 · Same journal
A Real‐World Cross‐Sectional Study on Suspected Mast Cell Activation Syndrome: Multiple Heterogeneous Symptoms Identified · Clinical and Translational Allergy · 2026 · Same journal
Patient‐Reported Outcome Measures as Predictive Tools for Disease Control in Chronic Rhinosinusitis With Nasal Polyps: A Prospective Study · Clinical and Translational Allergy · 2025 · Same journal
Unique Sensitization Patterns to Allergen Components in a Crustacean‐Allergic Australian Cohort · Clinical and Translational Allergy · 2026 · Same journal
Paucigranulocytic Asthma in Aspirin‐Hypersensitive Patients: Pleiotropic Regulation of Type 2 Biomarkers · Clinical and Translational Allergy · 2026 · Same journal